Type 2 Diabetes does not worsen prognosis in hepatocellular carcinoma

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 3, 2011, Pages 214-220

  Howell, J ^a   Yiu, M ^a   Gibson, R ^a   Thomson, B ^a   Stella, D ^a   Gorelik, A ^a   Prichard, P J ^a   Nicoll, A J ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE;

AGED; CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

MLCS; MLOWN;

EID: 80052323147     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2010.11.002     Document Type: Article

References (22)

1. Roberts, S.K., Kemp, W., Hepatocellular carcinoma in an Australian tertiary referral hospital 1975–2002: change in epidemiology and clinical presentation. J Gastroenterol Hepatol 22 (2007), 191–196.
2. El-Serag, H., Hepatocellular carcinoma, an epidemiological view. J Clin Gastroenterol 35 (2002), S72–S78.
3. Llovet, J., Burroughs, A., Bruix, J., Hepatocellular carcinoma. Lancet 362 (2003), 1907–1917.
4. Livraghi, T., Giorgie, A., Marin, G., et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 224:1 (1995), 47–54.
5. Livraghi, T., Melani, F., Di Stasi, M., et al. Sustained complete response and complication rates after radio-frequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice?. Hepatology 47:1 (2008), 82–89.
6. Camma, C., Schepis, F., Orlando, A., et al. Trans-chemoembolisation for unresectable hepatocellular carcinoma: meta-analysis of randomised-controlled trials. Radiology 224:1 (2002), 47–54.
7. Tazawa, J., Maeda, N., Suzuki, K., et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sc 47 (2002), 710–715.
8. Veldt, B., Chen, W., Janssen, H., Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47 (2008), 1856–1862.
9. Bugianesi, E., Review article: steatosis, the metabolic syndrome and cancer. Aliment Pharmacol Ther 22:S2 (2005), 40–43.
10. Chitturi, S., Farrell, G., Sollano, J., et al. Nonalcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J Gastroenterol Hepatol 22 (2007), 778–787.
11. Llovet, J.M., Bru, C., Bruix, J., Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999), 329–338.
12. Bruix, J., Sherman, M., AASLD guideline: management of hepatocellular carcinoma. 2006.
13. Brown, D., Jean-François, H., Geschwind, M.D., et al. Society of Interventional Radiology position statement on chemoembolisation of hepatic malignancies. J Vasc Interv Radiol 17 (2006), 217–223.
14. Llovett, J.M., Ricci, S., Mazzaferro, V., et al. Sorafenib in advanced hepatocellular carcinoma. NEJM 24:359 (2008), 378–390.
15. International Diabetes Institute, The Asia-Pacific perspective: redefining obesity and its treatment. 2000, Health Communications Australia, Melbourne.
16. Yuan, J.M., Govindarajan, S., Arakawa, K., Yu, M.C., Synergism of alcohol, diabetes and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the US. Cancer 101 (2004), 1009–1017.
17. Veldt, B.J., Chen, W., Heathcote, E.J., et al. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 47 (2008), 1856–1862.
18. Lai, M.S., Hsieh, M.S., Chiu, Y.H., Chen, T.H., Type 2 Diabetes and hepatocellular carcinoma: a cohort study in high prevalence area of hepatitis virus infection. Hepatology 43 (2006), 1295–1302.
19. Inoue, M., Iwasaki, M., Tsugane, S., et al. Diabetes mellitus and the risk of cancer. Arch Intern Med 166 (2006), 1871–1877.
20. Kawamura, Y., Ikeda, K., Arase, Y., et al. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. J Gastroenterol Hepatol 23 (2008), 1739–1746.
21. Khan, M., Saito, M., Shimamoto, K., et al. Relationship between hepatocellular carcinoma and impaired glucose tolerance among Japanese. Hepatogastroenterology 53:71 (2006), 742–746.
22. Bugianesi, E., McCullough, A., Marschesini, G., Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42 (2005), 987–1000.